Business
Practice ManagementMalpractice ConsultHealth Law & Policy
Media
Case-Based Peer PerspectivesInvestigator Perspectives Medical World NewsPodcastsUrology Medical PerspectivesUTv VideosPeer ExchangeSpecial ReportVirtual Tumor BoardInsightsMedcastPeers & Perspectives
Conferences
Conference ListingConference Previews Conference Recaps
Publications
Urology Times JournalEditorial Advisory BoardUrologists in Cancer CareSupplements and Featured PublicationsClinical Forums Recaps
More
CME/CE
Resources
Begin Your Journey: Tackling BurnoutSponsored MediaLive EventsInteractive ToolsJob BoardPartnersSponsored ResourcesTreatment Landscape Evolutions

Subscribe

  • Business
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Benign Conditions
  • Benign Prostatic Hyperplasia
  • Bladder Cancer
  • Female Urology
  • Genitourinary Cancers
  • Genomic Testing
  • Hormone Therapy
  • Kidney Cancer
  • Kidney Stones
    • Challenging Anatomy
  • Men's Health
  • Next-Generation Imaging
  • OAB and Incontinence
    • Voiding Dysfunction
  • Pediatrics
  • Prostate Cancer
    • Controveries in Urologic Cancer
    • Drug Therapy
  • Sexual Dysfunction
  • UTUC
  • Urologic Surgery
    • Cosmetic Surgery
Spotlight -
Peer Exchange|
Peers and Perspectives|
Case-Based Peer Perspectives|
Urology Times Journal
Advertisement

Michael E. Woods, MD

Advertisement

Articles by Michael E. Woods, MD

Gender disparities in bladder cancer management

BySpencer T. Hart, MD,Michael E. Woods, MD,Marcus L. Quek, MD
February 20th 2019

Poor outcomes in women may stem from diagnostic, therapeutic, and biologic factors.

Advertisement

Latest Updated Articles

  • Gender disparities in bladder cancer management
    Gender disparities in bladder cancer management

    Published: February 20th 2019 | Updated:



Advertisement
Advertisement

Trending on Urology Times

1

Mohit Khera, MD, recaps key takeaways from FDA panel on TRT for men

2

FDA approves niraparib plus abiraterone acetate with prednisone for BRCA2+ mCSPC

3

FDA approves zoliflodacin for uncomplicated urogenital gonorrhea

4

FDA approves first-line Zenflow system for the treatment of BPH

5

EMA recommends conditional approval of Anktiva in BCG-unresponsive NMIBC

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Job Board
  • Terms and Conditions
  • Privacy
  • Do not sell my Personnal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us